45
Nanopath Inc raises $5.3M under Reg D
Company raise · Raising · Offering $6M · Sold $5.3M · CAMBRIDGE, MA · filed 2025-02-06
47
Nanopath Inc raises $36.76M in biotech funding round under Reg D 506(b)
Company raise · Raising · CAMBRIDGE, MA · Form D filed 2026-11-13 · Follow Nanopath Inc →
Cambridge-based Nanopath Inc, a biotechnology company, is raising $36.76M and has sold $29.89M to 21 investors as of October 22, 2026. The offering remains open with $6.87M available under Regulation D exemption 506(b).
Emails for the 4 people on this filing, looked up when it is first revealed. Reveal
$10M+ raiseother
How this compares
- Among 442 fund launches filed from MA in the same window it is larger than 72%; the MA median is $2.4M.
- No earlier fund launch by this sponsor appears on EDGAR.
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
Raise progress
| Filed | Form | Sold | Investors | Change |
|---|---|---|---|---|
| 2025-02-06 | D | $5.3M | 5 | |
| 2026-11-13 | D | $29.9M | 21 | +$24.6M |
Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.
Nanopath on EDGAR
Earlier and related filings by the same issuer and sponsor.
People on the filing
| Amogha Tadimety | Executive Officer, Director |
| Alison Burklund | Executive Officer, Director |
| Jeff Crowe | Director |
| Aaron Sandoski | Director |
Signed by Amogha Tadimety, Co-Chief Executive Officer.
Why now — by persona
- Executive & technical recruiting
- B2B software & services sales
- Commercial banking / treasury
- D&O and management-liability insurance
- Outsourced accounting / CFO
5 hooks, one per persona, each citing this filing. Reveal
Filing contact
Phone ending 4542 and the street address from the filing. Reveal